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Abstract
In the last decades, the number of people suffering from dermatophytoses has seriously
increased, which may be due to the development of resistant strains to a range of anti-
fungal drugs. The present study was aimed to evaluate the antidermatophytic properties
of eight extracts from the selected spices and herbs, which were ethno-medicinally used
in Iran against Trichophyton mentagrophytes, Trichophyton interdigitale, Microsporum
canis, and Microsporum gypseum (10 strain of each). The in vitro antifungal activities of
the extracts from four spices and four plants were evaluated by the broth macro dilution
method against four dermatophyte strains. In addition, the in vivo therapeutic effects
of Myrtus communis L. and Cinnamomum zeylanicum Blume extracts (the most active
extracts) on dermatophytosis induced by M. canis and T. mentagrophytes in guinea pigs
were evaluated. Results of in vitro antifungal assay revealed that all the tested extracts
demonstrated both fungistatic and fungicidal activities with the geometric mean (GM)
MIC ranging from 0.058 to 3.73mg/ml and GM (MFC) ranging from 0.058 to 7.46mg/ml,
respectively. Two extracts (M. communis and C. zeylanicum) significantly inhibited the
growth of all the tested dermatophytes, while other extracts demonstrated weak (MICs of
>0.625mg/ml) to moderate (MICs ranging from 100 to 0.625mg/ml) activities. In vivo an-
tidermatophytic assay demonstrated that clotrimazole cured T. mentagrophytes and M.
canis infection on days 21 and 17, respectively, whereasM. communis and C. zeylanicum
extracts significantly (p < 0.05) cured T. mentagrophytes and M. canis infection on days
9 and 13 as well as 9, 11, respectively. Phytochemical screening showed the presence
of flavonoids, tannins, phenols, and alkaloids in M. communis and alkaloids, flavonoids,
and tannins in C. zeylanicum. Findings of the present study also provided the scientific
evidence that natural plants could be used in traditional medicine for the prevention and
treatment of dermatophytic infections.
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Introduction
One of the most important groups of fungi causing world-
wide human and animal infections is dermatophytes [1].
They are able to invade keratinized tissues, such as hair,
skin, and nails to produce an infection dermatophytosis,
which is commonly referred to as ringworm. There are dif-
ferent forms of the disease including tinea corporis, tinea
pedis, capitis, barbae, cruris, manum, and onychomycosis
[1]. The existing treatments for these infections are still
limited to a few antifungal agents. However, clinical val-
ues of these agents have been limited due to having high
toxicity and emergence of drug resistance in their anti-
fungal activities [2,3]. These factors emphasize the urgent
need for the development of new effective treatment alter-
natives. Since the last decades, plant extracts and plant-
derived compounds, due to having fewer side effects, low
cost, and high availability, have been valuable sources that
are commonly used to treat a wide range of disease con-
ditions including infectious diseases [4]. Spices and herbs
are a part of the daily food in several parts of the world,
comprise the most important products used for flavoring
foods and play a major role as the topical or systemic treat-
ment of a wide range of diseases including infectious dis-
eases. Beside their importance for general well-being, they
are frequent parts of traditional formulae [5]. Furthermore,
the diets rich in bioactive phytochemicals reduce the risk
of degenerative disorders such as cancer, diabetes, cardio-
vascular diseases, and oxidative dysfunction [6–8]. In Iran,
use of spices and other aromatic plants as food flavoring
has been an integral part of dietary behaviors for centuries.
To the best knowledge of the present authors, few stud-
ies have investigated the effects of Iranian medical spices
and herbs on dermatophytes. Therefore, the present study
was designed to evaluate the in vitro and in vivo antifun-
gal properties of eight extracts from the selected spices and
herbs that were ethno-medicinally used in Iran against some
pathogenic dermatophyte strains (Trichophyton mentagro-
phytes, Trichophyton interdigitale,Microsporum canis, and
Microsporum gypseum) with high local prevalence in the
southeast of Iran.
Material and methods
Chemicals
Crude powder of fluconazole, clotrimazole, and itracona-
zole as control drugs were obtained from Sigma-Aldrich
Chemical Company, GmbH, Riedstr. RPMI-1640 medium
with L-glutamine and sabouraud dextrose broth (SDA)
were purchased from Sigma-Aldrich, (St. Louis, MO, USA).
Also potato dextrose agar (PDA) was prepared from
Oxoid, Basingstoke,Hampshire, UnitedKingdom.All other
chemicals and solvents were of analytical grade.
Fungal strains
The strains of T. mentagrophytes, T. interdigitale,
M. canis, and M. gypseum (10 of each) used in this study
were clinical isolates obtained from nail, skin, or hair spec-
imens recovered from patients from Kerman General Hos-
pitals from January to December 2013. The strains were
identified using both macroscopic and microscopic conven-
tional standard methods such as slide culture, growth in
CMA with 1% glucose, sabouraud dextrose agar with 3%
NaCl, hair perforation, growth at 37◦C, urease activity,
and Trichophyton agar. Four standard strains of T. menta-
grophytes (ATCC 9533), T. interdigitale (ATCC 200099),
M. canis (ATCC 32903), and M. gypseum (ATCC 14683),
(American Type Culture Collection) were also used for
quality control of tests. T. mentagrophytesMYA-4439, the
dermatophyte quality control strain recommended for use
in CLSI document M38-A2, was included on each day of
testing. Sabouraud dextrose agar (SDA) was used for the
maintenance and culturing of fungal strains. Trichophyton
strains on the SDA colonies are generally flat and white to
cream in color and have a powdery to granular surface,
while Microsporum strains are glabrous, downy, wooly,
or powdery and white to beige or yellow to cinnamon
in color.
Collection of plant materials
The four spices and four plants investigated in this
work (Cinnamomum zeylanicum Blume,Zingiber officinale
Roscoe,Heracleum persicum Boiss, Elettaria cardamomum
L., Salvia officinalis L., Calendula officinalis L., Myrtus
communis L., and Mentha spicata L.) were collected from
rural regions of Kerman province, southeast of Iran from
May to September 2012. They were identified by a botanist
of the Botany Department of Shahid Bahonar University,
Kerman, Iran. Voucher specimens have been deposited in
the Herbarium of Department of Pharmacognosy, School
of Pharmacy, Kerman University of Medical Sciences,
Kerman, Iran (Table 1).
Preparation of extracts
The powdered air-dried sample (100 g) from each plant
was separately extracted by percolation method with
methanol (80%) successively for 72 h in room tempera-
ture. The extracts were passed through filter paper (What-
man No.3, Sigma, Germany) to remove plant debris. The
extracts were finally concentrated in vacuum at 50◦C using
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Table 1. Characterization of eight medicinal plants of used in the present study.
No. Scientific Name Family Common Name Part used Voucher No.
1 Calendula officinalis L. Asteraceae Marigold Flower KF 1367
2 Cinnamomum zeylanicum Blume. Lauraceae True cinnamon Bark KF 1121
3 Elettaria cardamomum L. Zingiberaceae Green cardamom Seed KF 1246
4 Heracleum persicum Boiss. Apiaceae Persian Hogweed Leaf, Seed KF 1143
5 Mentha spicata L. Lamiaceae Spear mint Leaf KF 1420
6 Myrtus communis L. Myrtaceae Myrtle Aerial parts KF 1356
7 Salvia officinalis L. Lamiaceae Sage Flower KF 1432
8 Zingiber officinale Roscoe Zingiberaceae Ginger Rhizome KF 1457
a rotary evaporator (Heidolph, Germany) to remove solvent
(methanol) and stored at −20◦C, until testing [9].
Phytochemical analysis
The phytochemical analysis of the methanolic extracts was
carried out using the following reagents and chemicals: [10]
Alkaloids with Mayer and Bushard’s reagent, flavonoids by
the use of mg and HCl; tannins with 1% gelatin; and 10%
NaCl solutions and saponins with the ability to produce
suds.
Animals
Inbred male guinea pigs (400 ± 50 g) were bred in Animal
House, Faculty of Medicine, Kerman University of Medical
Science (Kerman, Iran). They were housed in a colony room
with a 12:12 h light, dark cycle at 21± 2◦C and handled ac-
cording to the standard protocols for the use of laboratory
animals [11]. They were randomly selected and caged indi-
vidually or in a group, depending on the type of assay, for
5 days prior to the start of the test for acclimatization to the
test conditions. The animals were also randomly assigned
to control and test groups.
Minimum inhibitory concentration (MIC) determi-
nation
The MIC of extracts against tested dermatophytes was de-
termined by broth macrodilution method, according to the
protocol M38-A2 of the Clinical and Laboratory Standards
Institute (CLSI) for filamentous fungi with some modifica-
tions [12]. Prior to testing, dermatophyte strains were sub-
cultured on PDA slants and incubated at 30◦C for 7 to
10 days. Mature colonies were covered with 2ml of ster-
ile physiological saline (0.85%), suspensions were prepared
by gently probing the colony with the tip of a sterile Pas-
teur pipette and transferred to a sterile conical tube, the
final volume being adjusted to 5ml with saline. The re-
sulting mixture of conidia and hyphal was vortex mixed
for 15 seconds and the heavy particles allowed to settle
for 5–10 minutes. The upper homogeneous suspension was
used for further testing. The resulting conidia suspension
was counted in a Neubauer chamber and standardized to
concentrations of 1 × 105 to 5 × 105 cfu/ml. This sus-
pension was further diluted 1:10 with RPMI-1640 medium
broth with L-glutamine and without sodium bicarbonate
to final concentrations of 1 × 104 to 5 × 104 cfu/ml. For
the broth macrodilution method, 0.9ml of the final conidia
suspensions were mixed with 0.1ml of the different concen-
trations of various extracts (0.0625–16mg/ml) in test tubes
and incubated at 30◦C for 7 days. The positive control
tube contained 0.9ml of conidial suspension and 0.1ml of
RPMI-1640, and the negative one contained 1ml of RPMI-
1640 only. Theminimum concentrations at which no visible
growth was observed were defined as the MIC, which were
expressed in mg/ml.
Minimum fungicidal concentration (MFC)
determination
To determine minimum fungicidal concentration (MFC)
values, after reading the corresponding MIC values, 100μl
samples from all optically clear tubes (complete growth in-
hibition) plus the last tube showing growth were subcul-
tured on SDA Petri dishes. The dishes were incubated at
35◦C for a minimum of 3 days, until growth was clearly
visible in the control samples, and MFC values were de-
termined as the lowest concentration of extracts for which
there was no visible growth.
In vivo antidermatophytic activity
Ethical statement
The experimental procedures carried out in this survey were
in compliance with Guidelines of Kerman University of
Medical Science (Kerman, Iran) for the care and use of
laboratory animals in line with Animal Ethics Committee
(83/22).
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Dermal infection of animals
In the present study, 55 male guinea pigs were used to eval-
uate in vivo antidermatophytic activity of the extracts. They
were randomly assigned to different treatment groups. For
each extract, there were four groups, each containing five
animals. Three control groups were used; simple control
with no infection and no treatment, untreated control re-
ceiving distilled water, and positive control group treated
with reference antifungal drug clotrimazole at 10 mg/kg of
body weight (BW). The hair of an area (5 cm2) on the back
of each guinea pig was shaved, and the skin was slightly
scraped by a single use scalpel. Then, 50 μl of the suspen-
sion of T. mentagrophytes or M. canis was inoculated to
the surface of about 3 cm2 area within the shaved zone [13].
Evidence of the infection was revealed by direct observation
of the infected area, followed by agar culture of scrapings
from the area, and microscopic observation of the resulting
fungi from the scrapings.
Treatment of infected animals
Animals were treated by topical application of each extract
at concentrations 1 and 2 g/kg BW (selection of these con-
centrations was based on the primary experiments which
also showed that both extracts had no toxicity at these
concentrations), started on the sixth day after animal in-
fection and continued daily (each morning) until achieving
complete recovery. Effect of the extracts against dermato-
phytes was evaluated by culturing skin scrapings and hair
on SDA for the recovery of viable dermatophytes. These
scrapings and hair were collected from the active border of
the infection site every two days [14]. The cultures were
incubated for 15 days at 28◦C. The results were recorded in
terms of percentage culture recovery of dermatophytes of
the infected site.
% Culture recovery = Total number of sites showing the presence of dermatophytes
Total number of infected sites
× 100
Statistical analysis
SPSS software (ver. 17, SPSS Inc., Chicago) was used for
data entry and statistical analysis. Geometric mean (GM)
of MIC and MFC was obtained for all the isolates tested
and the differences between the groups were determined
using one way analysis of variance (ANOVA). P-value of
less than .05 was considered to be statistically significant.
Results
Phytochemical analysis
The phytochemical screening of the methanolic extracts
showed the presence of flavonoids, tannins, phenols, and
alkaloids in M. communis and alkaloids, flavonoids, and
tannins in C. zeylanicum.
In vitro antidermatophytic activity
Results of in vitro antifungal assay (GM of MIC and
MFC values) are presented in Table 2. The findings in-
dicated that all the extracts demonstrated both fungistatic
and fungicidal activities with the GM (MIC) ranging from
0.058 to 3.73mg/ml and GM (MFC) ranging from 0.058 to
7.46mg/ml.M. communis and C. zeylanicum extracts were
significantly (P< .05) much more effective than the extracts
of other plants, fluconazole, and clotrimazole once they ex-
hibited lower MIC and MFC values for all the tested der-
matophyte strains, whereas the lowest antidermatophytic
effect was related to the extracts of S. officinalis and M.
spicata. Among the tested dermatophytes, M. canis was the
most sensitive one to the extracts of the selected plants,
while M. gypseum was less effective. Moreover, clotrima-
zole, fluconazole, and itraconazole as control drugs exhib-
ited both fungistatic and fungicidal activities with the GM
(MIC) ranging from 0.0042 to 0.217mg/ml andGM (MFC)
ranging from 0.128 to 0.238mg/ml against the tested der-
matophytes. However, the difference in antidermatophytic
effects between the extracts and the itraconazole was not
statistically significant (P > .05), whereas it was statisti-
cally significant (P < .05) between M. communis and C.
zeylanicum extracts and fluconazole. Since the extracts of
M. communis and C. zeylanicum were the most effective
ones against the tested dermatophytes on in vitro model,
the in vivo therapeutic effect of these extracts on dermato-
phytosis induced by T. mentagrophytes and M. canis in
guinea pigs was also evaluated.
In vivo antidermatophytic activity
Figures 1 and 2 demonstrate the in vivo efficacy ofM. com-
munis and C. zeylanicum extracts (the most active extracts)
for the dermatophytosis induced in guinea pigs. Both ex-
tracts were found to be efficacious in a time-dependent
manner compared with clotrimazole as the positive con-
trol (P < .05). M. communis with the concentration of
1 g/kg BW resulted in the complete cure of T. mentagro-
phytes and M. canis infection on days 11 and 13, respec-
tively; while the concentration of 2 g/kg BW significantly
(p < 0.05) cured T. mentagrophytes and M. canis infection
on days 9 and 13, respectively. C. zeylanicum extract at
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Figure 1. Evaluation of the percent culture recovery during treatment of
infected guinea pigs with M. communis extract: concentration of 1 g/kg
BW (a) and concentration of 2 g/kg BW (b).
the concentration of 1 g/kg BW resulted in the complete
cure of T. mentagrophytes and M. canis infection on days
11 and 13, respectively, whereas 2 g/kg BW concentration
of this extract significantly (P < .05) cured T. mentagro-
phytes andM. canis infection on days 9 and 11, respectively.
Moreover, the clotrimazole resulted in the complete cure of
T. mentagrophytes and M. canis infection on days 21 and
17, respectively. In the control model, the hair culture was
positive, which exhibited 100% culture recovery between
days 3 and 21.
Discussion
Historically, herbs and spices have been used as a valu-
able natural resource for traditional remedy [15]. In re-
cent years, development of adverse effects and microbial
resistance to the chemically synthesized drugs has caused
changes in the situation and interest in the field of eth-
nobotanical research [16,17]. Therefore, the present study
was aimed to investigate the in vitro and in vivo antifungal
properties of 8 extracts from the spices and herbs ethno-
medicinally used in Iran against some pathogenic dermato-
phyte strains. Results of in vitro antifungal assay revealed
that all the tested extracts demonstrated both fungistatic
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Figure 2. Evaluation of the percent culture recovery during treatment of
infected guinea pigs with C. zeylanicum extract: concentration of 1 g/kg
BW (a) and concentration of 2 g/kg BW (b).
and fungicidal activities with the GM (MIC) ranging from
0.058 to 3.73mg/ml and GM (MFC) ranging from 0.058
to 7.46mg/ml. Each of the extracts tested in the present
study indicated an antifungal activity on at least one of the
tested dermatophytes. However, differences were observed
between antifungal activities, since most of the tested plant
extracts exerted a broad antifungal spectrum. These varia-
tions in antifungal activity could be due to the differences
in the chemical composition of these plants, because the
secondary metabolites of the plants have many effects in-
cluding antimicrobial properties [16]. Furthermore, the ac-
tivity of the plant extracts could be influenced by the nature
of the plant material or its origin as well as the climatic
conditions in which it grew, the used plant parts, or the
solvent used for extraction, because plants have different
constituents depending on these factors [18]. Antimicrobial
activity of plant extracts is considered to be significant if
MIC values are below 100 μg/ml for crude extract and
moderate when MICs vary from 100 to 625 μg/ml [18].
In this study, two extracts (25%) significantly inhibited the
growth of all the tested dermatophytes, while other extracts
demonstrated weak to moderate activities. These findings
were in agreement with those of previous studies, reporting
that the commonly used herbs and spices had antimicrobial
properties that, in some cases, can be used in traditional
medicine [19]. Since M. communis and C. zeylanicum ex-
hibited the best activity against the tested drematophytes
in the in vitro model, thus the in vivo therapeutic effect
of these extracts was investigated against dermatophytosis
induced in guinea pig model. Dermatophytosis induced in
guinea pigs is a well established predictive model for test-
ing topical antifungal agents [13]. This model was used in
this study and allowed to indicate that the crude extract of
M. communis and C. zeylanicum had an in vivo antifungal
activity against some pathogenic strains of dermatophytes.
In this model, the significant efficacy of M. communis and
C. zeylanicum extracts, particularly at the concentration
of 2 g/kg BW, was observed for dermatophytosis induced
in guinea pigs. Skin redness, lesion severity, and dermato-
phyte occurrence were significantly reduced following the
application of the extracts. The efficacy was confirmed by
the recurrence of hair growth in the infected areas in treat-
ment models compared with control group. When clotri-
mazole cured T. mentagrophytes and M. canis infection on
days 21 and 17, respectively, M. communis and C. zeylan-
icum extracts significantly (P < .05) cured T. mentagro-
phytes and M. canis infection on days 9 and 13 as well
as 9 and 11, respectively. Therefore, the highest activity of
the aforementioned extracts was observed against T. men-
tagrophytes followed by M. canis infection. In line with
the present findings, several studies have been reported the
antidermatophytic action of the 1% oil-petroleum jelly for-
mulation of the essential oil of Chenopodium ambroisoides
and formulated extract-oil (5%) of Polyscias fulva curing
T. mentagrophytes-induced dermatophytosis in guinea pigs
on days 15 and 14, respectively [20,21]. In addition, similar
efficacies have been proven on the extract-cream formula-
tion of Zataria multiflora and Eucalyptus camaldulensis
[22,23].
Various pharmacological activities such as antioxidant,
anti-inflammatory, anticancer, and antimicrobial effects
have been related to M. communis and C. zeylanicum
[24,25]. In addition, phytochemical screening of the crude
extract of M. communis and C. zeylanicum has revealed
the presence of tannins, alkaloids, flavonoids, and phenols
in these plants. Individual activities of these compounds
have also been proven [16]. Various studies have reported
the potent antifungal effects of these compounds and their
derivatives such as thymol and carvacrole against some
pathogenic fungal strains [26–28]. Carvacrol was active
in vitro against 100 clinical isolates of Candida albicans
with MICs ranging from 0.125 to 0.004%. MIC (50) and
MIC (90) values of carvacrol were observed at 0.064 and
0.125mg/ml, respectively [26]. In addition, thymol was
more effective againstT. rubrumwithMIC andMFC values
of 11.7 to 23.4 μg/ml, respectively [27].
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Therefore, phytoconstituents in these plants could be
responsible for their antidernatophytic activity although
their exact mode of action is poorly understood. How-
ever, it has been previously shown that antimicrobial effects
of carvacrol and thymol are attributed to their ability to
permeabilize and depolarize the cytoplasmic membrane
[29]. In dermatophytic infections, inflammatory responses
are usually defined by a greater degree of redness and scaling
at the edges of the lesions, or occasionally, blister forma-
tions [30]. During the inflammation, reactive oxygen species
and free radicals with many physiological and pharmaco-
logical adverse effects, including skin irritation, are pro-
duced [31]. However, some compounds of M. communis
and C. zeylanicum extracts such as phenols and tannins are
known for their ability in protecting cells against reactive
oxygen species and free radical-induced toxicity [32].
In conclusion, this study demonstrated the antidermato-
phytic effects of M. communis and C. zeylanicum extracts.
Findings of the present study also provided the scientific
evidence that natural plants could be used in traditional
medicine for the prevention and treatment of dermatophytic
infections.
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